Caspase-8: not so silently deadly

被引:96
|
作者
Feltham, Rebecca [1 ,2 ]
Vince, James E. [1 ,2 ]
Lawlor, Kate E. [1 ,2 ]
机构
[1] Walter & Eliza Hall Inst Med Res, Inflammat Div, 1G Royal Parade, Parkville, Vic 3052, Australia
[2] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia
来源
关键词
NLRP3 INFLAMMASOME ACTIVATION; NF-KAPPA-B; A20 RESTRICTS UBIQUITINATION; RECEPTOR-INDUCED APOPTOSIS; NECROPTOTIC CELL-DEATH; MODIFYING ENZYME A20; PROGRAMMED NECROSIS; C-FLIP; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; MEDIATED APOPTOSIS;
D O I
10.1038/cti.2016.83
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Apoptosis is a caspase-dependent programmed form of cell death, which is commonly believed to be an immunologically silent process, required for mammalian development and maintenance of cellular homoeostasis. In contrast, lytic forms of cell death, such as RIPK3-and MLKL-driven necroptosis, and caspase-1/11-dependent pyroptosis, are postulated to be inflammatory via the release of damage associated molecular patterns (DAMPs). Recently, the function of apoptotic caspase-8 has been extended to the negative regulation of necroptosis, the cleavage of inflammatory interleukin-1 beta (IL-1 beta) to its mature bioactive form, either directly or via the NLRP3 inflammasome, and the regulation of cytokine transcriptional responses. In view of these recent advances, human autoinflammatory diseases that are caused by mutations in cell death regulatory machinery are now associated with inappropriate inflammasome activation. In this review, we discuss the emerging crosstalk between cell death and innate immune cell inflammatory signalling, particularly focusing on novel non-apoptotic functions of caspase-8. We also highlight the growing number of autoinflammatory diseases that are associated with enhanced inflammasome function.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Caspase-8 function, and phosphorylation, in cell migration
    Keller, Nadine
    Ozmadenci, Duygu
    Ichim, Gabriel
    Stupack, Dwayne
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2018, 82 : 105 - 117
  • [42] The role of caspase-8 in resistance to cancer chemotherapy
    Kim, PKM
    Mahidhara, R
    Seol, DW
    DRUG RESISTANCE UPDATES, 2001, 4 (05) : 293 - 296
  • [43] Differential inactivation of caspase-8 in lung cancers
    Shivapurkar, N
    Toyooka, S
    Eby, MT
    Huang, CX
    Sathyanarayana, UG
    Cunningham, HT
    Reddy, JL
    Brambilla, E
    Takahashi, J
    Minna, JD
    Choudhary, PM
    Gazdar, AF
    CANCER BIOLOGY & THERAPY, 2002, 1 (01) : 65 - 69
  • [44] Molecular cloning and characterization of mouse caspase-8
    Sakamaki, K
    Tsukumo, S
    Yonehara, S
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 253 (02): : 399 - 405
  • [45] Is caspase-8 a neuroendocrine lung tumor supressor?
    Mazumder, S
    Almasan, A
    CANCER BIOLOGY & THERAPY, 2002, 1 (01) : 70 - 71
  • [46] An induced proximity model for caspase-8 activation
    Muzio, M
    Stockwell, BR
    Stennicke, HR
    Salvesen, GS
    Dixit, VM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (05) : 2926 - 2930
  • [47] Non-apoptotic functions of caspase-8
    Maelfait, Jonathan
    Beyaert, Rudi
    BIOCHEMICAL PHARMACOLOGY, 2008, 76 (11) : 1365 - 1373
  • [48] TRAIL promotes entosis through Caspase-8
    Bozkurt, Emir
    Dussmann, Heiko
    Prehn, Jochen H.
    CANCER RESEARCH, 2018, 78 (13)
  • [49] Potentiation of neuroblastoma metastasis by loss of caspase-8
    Stupack, DG
    Teitz, T
    Potter, MD
    Mikolon, D
    Houghton, PJ
    Kidd, VJ
    Lahti, JM
    Cheresh, DA
    NATURE, 2006, 439 (7072) : 95 - 99
  • [50] Insights into the regulatory mechanism for caspase-8 activation
    Donepudi, M
    Mac Sweeney, A
    Briand, C
    Grütter, MG
    MOLECULAR CELL, 2003, 11 (02) : 543 - 549